UnknownNot Applicable

Investigation for Health Efficacy of Infrared-C Radiation on Diabetes Patients in Senior's Activity Center

Taiwan64 participantsStarted 2018-03-23

Plain-language summary

Hyperglycemia caused by diabetes will bring us the long-term damage，it causes glycation. The combination of sugar molecules and protein molecules will transform to advanced glycation end products (AGEs) and produce a lot of free radicals to caused inflammatory reactions, forming various comorbidities, affecting the function of different organs, especially the eyes, kidneys, nervous system, heart, blood vessels and damage to bone structure and bone Quality, which leads to bone loss. Therefore, the development of alternative therapies is important for the treatment of diabetes. We assume the 4 months experiment can normalize subjects HbA1c.

Who can participate

Age range50 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * HbA1c higher than 6.8% or fasting blood sugar higher than 126mg/dL; * Conscious, mental and cognitively normal; * no obstacles in action; * can read, write and communicate with mandarin, taiwanese and hakka. Exclusion Criteria: * Inflammatory skin wounds on the neck, back, lower back or lower leg; * obstacles in communication; * People with disabilities, epilepsy, and other unacceptable warming treatments; * When the subject finds that he or she is unwell during the procedure, the experiment is terminated and take care by the medical staff.

What they're measuring

Hemoglobin A1c, HbA1c

Timeframe: Baseline to 4 months

Fasting Blood Sugar, GLU-AC

Timeframe: Baseline to 4 months

Insulin

Timeframe: Baseline to 4 months

Superoxide, O2-

Timeframe: Baseline to 4 months

Osteocalcin

Timeframe: Baseline to 4 months

Procollagen-I N-telopeptide, PINP

Timeframe: Baseline to 4 months

C-telopeptide of type I collagen，CTx

Timeframe: Baseline to 4 months

Total Antioxidant Capacity, TAC

Timeframe: Baseline to 4 months

Advanced glycation end-product，AGEs

Trial details

NCT IDNCT04177420

SponsorNanhua University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-31

Contact for this trial

PIN-FAN CHEN, Doctor

+886929206688 pinfan1973@gmail.com

View on ClinicalTrials.gov More Diabetes Mellitus, Type 2 trials

Plain-language summary

Who can participate

Age range50 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Hemoglobin A1c, HbA1c

Timeframe: Baseline to 4 months

Fasting Blood Sugar, GLU-AC

Timeframe: Baseline to 4 months

Insulin

Timeframe: Baseline to 4 months

Superoxide, O2-

Timeframe: Baseline to 4 months

Osteocalcin

Timeframe: Baseline to 4 months

Procollagen-I N-telopeptide, PINP

Timeframe: Baseline to 4 months

C-telopeptide of type I collagen，CTx

Timeframe: Baseline to 4 months

Total Antioxidant Capacity, TAC

Timeframe: Baseline to 4 months

Advanced glycation end-product，AGEs